Yong Wu

11PUBLICATIONS
12CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 13, 2022
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.

Qiongyu Hao, Zhimin Huang, Qun Li

|Dec 14, 2020
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.

Qiongyu Hao, Piwen Wang, Pranabananda Dutta

|Aug 22, 2020
Association of an anaplastic lymphoma kinase pathway signature with cell de-differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer.

Dingxie Liu, Yong Wu

|Oct 31, 2019
PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.

Qun Li, Qiongyu Hao, Wei Cao

|Feb 23, 2019
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.

Wei Cao, Jieqing Li, Qiongyu Hao

|Feb 14, 2018
Corrigendum to "Metabolic Syndrome, Inflammation, and Cancer".

Yong Wu, Yunzhou Dong, Shengzhong Duan

Pageof 2

Frequent Collaborators

4 joint publications

Yunzhou Dong

2 joint publications

Qiongyu Hao

1 joint publications

Mei-Zhen Cui

1 joint publications

Xuemin Xu